Yield10 Bioscience Valuation
| YTENDelisted Stock | USD 1.90 0.04 2.06% |
Based on Macroaxis valuation methodology, the company appears to be fairly valued. Yield10 Bioscience maintains a prevalent Real Value of $1.87 per share. The last-minute price of the company is $1.9. Our model calculates the value of Yield10 Bioscience from examining the company fundamentals such as Shares Outstanding of 642.54 K, return on asset of -1.5, and Operating Margin of (240.28) % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Yield10 Bioscience's price fluctuation is very steady at this time. Calculation of the real value of Yield10 Bioscience is based on 3 months time horizon. Increasing Yield10 Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Yield10 Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Yield10 Stock. However, Yield10 Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.9 | Real 1.87 | Hype 1.9 | Naive 1.82 |
The intrinsic value of Yield10 Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Yield10 Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Yield10 Bioscience helps investors to forecast how Yield10 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Yield10 Bioscience more accurately as focusing exclusively on Yield10 Bioscience's fundamentals will not take into account other important factors: Yield10 Bioscience Total Value Analysis
Yield10 Bioscience is at this time forecasted to have valuation of 3.96 M with market capitalization of 1.85 M, debt of 3.18 M, and cash on hands of 10.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Yield10 Bioscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.96 M | 1.85 M | 3.18 M | 10.16 M |
Yield10 Bioscience Investor Information
About 13.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 43.68. Yield10 Bioscience last dividend was issued on the 16th of January 2020. The entity had 1:24 split on the 3rd of May 2024. Based on the measurements of operating efficiency obtained from Yield10 Bioscience's historical financial statements, Yield10 Bioscience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Yield10 Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Yield10 Bioscience has an asset utilization ratio of 1.54 percent. This suggests that the Company is making $0.0154 for each dollar of assets. An increasing asset utilization means that Yield10 Bioscience is more efficient with each dollar of assets it utilizes for everyday operations.Yield10 Bioscience Ownership Allocation
Yield10 Bioscience maintains 12.59 (%) of its outstanding shares held by insiders and 11.79 (%) owned by institutional investors.Yield10 Bioscience Profitability Analysis
The company reported the previous year's revenue of 60 K. Net Loss for the year was (14.46 M) with loss before overhead, payroll, taxes, and interest of (7.3 M).About Yield10 Bioscience Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Yield10 Bioscience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Yield10 Bioscience based exclusively on its fundamental and basic technical indicators. By analyzing Yield10 Bioscience's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Yield10 Bioscience's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Yield10 Bioscience. We calculate exposure to Yield10 Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Yield10 Bioscience's related companies.Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts. Yield10 Bioscience operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
Yield10 Bioscience Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 331.1 K |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Yield10 Stock
If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |